The next CEEGOG meeting will be scheduled for May 2025 and held in Prague. At this time, we cannot confirm the exact date, but it will be one of the following dates: 15 MAY, 16 MAY, 22 MAY, 23MAY

Please be so kind and save all those days. We hope to confirm the date of the annual CEEGOG meeting by the end of this year.  

We are pleased to inform you that recently an article summarizing the final results of the CEEGOG ox-01/HE4-FU-OVCA study has been published. The CEEGOG ox-01/HE4-FU-OVCA study was the first CEEGOG study to be proposed and approved, focusing on the role of the HE4 marker in the follow-up of advanced ovarian, fallopian tube, and primary peritoneal cancer. The article was published in the Cancers journal,  and for your reference, is to be found in the CEEGOG Members´ shared area. Once again, we sincerely thank all participating sites for their valuable cooperation in the CEEGOG ox-01 study. It was a great pleasure for us to work with each of you!

The first GCIG Cervical Cancer Consensus Conference which focused on Clinical Research  was held in Dublin in Mid-October 2024. Dr. Zoltán Novák (Hungarian National Oncological Institute, Hungary) and Professor David Cibula (General University Hospital in Prague, the Czech Republic) represented CEEGOG there. The topics for discussions have been divided in four groups, i.e. Diagnosis and Staging, Early Cervical Cancer, Locally Advanced Cervical Cancer and Metastatic and Recurrent Disease. The main points of the consensus conference have been summarised in the statements to be published.

The Fall ENGOT meeting took place in Amsterdam at the end of September last. CEEGOG was represented by its Chairman Prof. David Cibula and the administrative Manager Mrs. Ivana Nohová.

On the first day, the meeting of Operationals and also the strategic meeting were held. At the meeting of the Operationals, we discussed group experience with the CTIS and regulatory authority surveillance which is one of the Sponsor´s responsibilities for each trial. The main discussion aimed at the feedback from the Working groups as defined by the ENGOT Strategic Group last year. As a reminder, those groups deal with the effective coordination and communication, with academic studies promotion, sustainabiility and early development of new drugs, mentoring groups and young investigators, the ENGOT database and relationship with non-European groups. The Update has also been provided by the Contract working group and Budgeting working group.  

The assembly meeting was held on September 27, 2024. From the CEEGOG studies, the update on the SENTIX study was provided.Twelve new trial proposals are currently developing, and each of them is now in a different phase of negotiation with the Pharmaceutical companies and of trial preparation. The CEEGOG members will be informed on each trial once the trial is prepared for country and site selection.  Among the new trial ideas, which were introduced at the ENGOT meeting, it is worth mentioning that CEEGOG has been appointed as the Lead Engot group for the commercial trial entitled AZALEA and sponsored by Abbvie. We look forward to cooperating on this exciting study!

The election of new CEEGOG leadership was conducted at the CEEGOG meeting held in Prague on JUNE 14, 2024. The new CEEGOG leadership consists of the following representatives: Chair DAVID CIBULA (General University Hospital in Prague, Czech Republic); Vice-Chair FILIP FRÜHAUF (General University Hospital in Prague, Czech Republic); Financial Manager ANDREJ COKAN (University Medical Centre Maribor, Slovenia) and Controller ZOLTÁN NOVÁK (Hungarian National Oncological Institute, Hungary).

Article 13 of the CEEGOG Bylaws stipulates the setting up of the Scientific committee consisting of 5 members, each one of them from a different center, representing at least 4 countries. The following representatives were elected to be members of the CEEGOG Scientific committee:

MIHAI CAPILNA (First Obst. and Gyn. Clinic, University of Medicine and Pharmacy Targu Mures, Romania), ANDRAŽ DOVNIK (University Medical Centre Maribor, Slovenia), DINA KURDIANI (Institute of Clinical Oncology, Georgia), MIKULÁŠ REDECHA (Bory Hospital - Penta Hospitals, Slovakia), VLADYSLAV SUKHIN (Grigoriev Institute for Medical Radiology, Kharkov, Ukraine).

Congratulations to the newly elected officers and Scientific committee members!

We hope that CEEGOG under the new leadership, and with the help of the newly elected Scientific members, will continue in its gradual development, and all CEEGOG countries and sites will be involved in our research activities and clinical trials.

This year´s annual CEEGOG meeting was held in Prague, on JUNE 14-15, 2024. 52 participants representing 33 sites from 11 CEEGOG countries attended the meeting.

Apart from electing the new CEEGOG leadership and new members of the Scientific committee, the meeting brought information on the progress of the running ENGOT and CEEGOG studies, and of the studies under preparation, and also about the newly planned ENGOT studies.

A very interesting highlight of the meeting was the part dedicated to country presentations summarizing the status of gynecology oncology care organization, access to innovative treatment, and the readiness for and barriers to conducting academic studies. We would like to express our thanks to Mirela Kekic (Croatia), David Cibula (Czech Republic), Dina Kurdiani (Georgia), Zoltán Novák (Hungary), Igor Aluloski (North Macedonia), Olga Matylevich (Republic of Belarus), Irina Tripac (Republic of Moldova), Mihai Capilna (Romania), Mikuláš Redecha (Slovakia), Andrej Cokan ( Slovenia) and Vladyslav Sukhin (Ukraine) who prepared and delivered the presentations on the situations in their countries.

Four new study proposals were introduced and are expected to be initiated in the CEEGOG countries this year.

Next meeting will be scheduled for MAY or JUNE 2025 according to the preferences of the individual CEEGOG members. Thank you all for attending the meeting and the garden reception, and for your continued support to CEEGOG. 

A short MEETING of the CEEGOG sites will take place during the upcoming ESGO congress in Barcelona.The aim is to briefly discuss collaboration on clinical trials and the cooperation opportunities within CEEGOG/ENGOT/GCIG with you. You are cordially invited to the meeting. We look forward to meeting with all of you in Barcelona!


The MEETING DETAILS are as follows: 

Date: Friday, MARCH 8 

Time: 12.00 pm – 12.40 pm (CET)

Venue: room 122, floor P1 of  Barcelona International Convention Centre - CCIB

Address: Plaça de Willy Brandt, 11-14, 08019 Barcelona

 

As of October 15, 2023, the Polish sites will not be further involved in CEEGOG. The Polish group named PGOG has become so independent and experienced that it no longer needs the support of the CEEGOG office for non-commercial studies. Henceforth, PGOG will manage the involvement of the Polish sites in both commercial and academic trials. We highly appreciate the collaboration with the CEEGOG Polish sites and their representatives so far, and would like to express our huge thanks therefor. We look forward to further cooperation with the Polish sites within clinical research under the PGOG umbrella.

A short MEETING of the CEEGOG sites will take place during the upcoming ESGO congress in Istanbul. The aim is to briefly discuss collaboration on clinical research within CEEGOG and ENGOT. You are cordially invited to the meeting. We look forward to meeting with all of you in Istanbul!

The MEETING DETAILS are as follows:   

Date: Friday, September 29  

Time: 1 p.m. – 2 p.m. (TRT) 

Venue: lounge Hamidiye, floor B2 of ICC Congress Hall    

This year´s annual CEEGOG meeting is scheduled for December 8, 2023. Please save the date! The meeting is taking place in Prague at the Department of Obstetrics and Gynecology of the General University Hospital in Prague.      

Please do not miss the chance to include your proposals for new collaborative projects in the meeting agenda, and send your proposals to the CEEGOG office by the end of this October.   

We hope to meet you all personally this December, and to discuss research in gynecology oncology and the clinical trials conducted under the CEEGOG umbrella. 

We look forward to meeting you all in Prague!

The GCIG Spring meeting was held in Chicago on May 31 – June 1, 2023. CEEGOG was represented there by its Vice- Chair, Dr. Filip Frühauf, and by the CEEGOG Manager, Ivana Nohová, who attended the meeting as the online participants. 

As previously agreed, mostly academic studies were presented during the GCIG meetings. It provided a broader framework for discussion on the hot topics such as de-escalation of Parpi maintenance, benefit from densification of chemotherapy in patients with poor prognostic ovarian cancer, diversity of the HRD tests availbale, symptom benefit, toxicity of treatment and impact on daily activities to be measured by using the so- called MOST questionnaires which are validated instruments developed by GCIG.  

 

The need to conduct trials focusing on HRP/non-HRD patients, patients with DNA mutations associated with CCNE1 amplification and on the treatment of clear cell carcinoma was highligted. Further personalized medicine, quality of life measurements, ethical and race diversity were also stressed. 

Discussion about harmonization of documents used in international trials, patient involvement within clinical research, and trial budgeting were conducted. 

An update was provided on the Italian project to develop a deep learning system to predict the HRD status from ovarian cancer pathology slides, and on the preparation of the new integrated  guidelines of ESGO, EURACAN and WSN for uterina sarcoma. 

Further, it was proposed to establish an International Neoadjuvant Endometrial Cancer Consortium in order to avoid multiple small studies with heterogenous patient populations, interventions and differences in pathological assessment. 

The Endometrial cancer consensus conference 2023 is scheduled for November in South Korea. Two CEEGOG representatives, namely Dr. Zoltán Novák from Budapest and Dr. Filip Frühauf from Prague have been approved by GCIG to be part of the working groups. 

And last but not least, an update on the CCRN activities and educational symposiums was provided. The GCIG mtg was concluded with an impressive speech on the lack of available treatment in Africa  which was delivered by the representative from South Africa. Afterwards, the need to develop further GCIG projects, which are  also meant for African patients, was stressed.

  1. ENGOT Advisory Board, April 2023
  2. ENGOT mtg in Milano, March 9 – 10, 2023
  3. ENGOT-ENYGO-GCA workshop in Malaga, December 8 – 10, 2022
  4. GCIG Autumn meeting, October 25 - 26, 2022
  5. ENGOT meeting in Berlin, October 6 - 7, 2022
  6. CEEGOG meeting in Prague on November 28, 2022
  7. GCIG SPRING meeting, June 1- 3, 2022
  8. ENGOT meeting in Copenhagen, April 28 – 29, 2022
  9. CEEGOG Annual virtual meeting on December 10, 2021
  10. GCIG Autumn meeting, November 8 – November 19, 2021